ArticleInternational urology and nephrology2026
Mortality Trends from Acute MI with Underlying CKD in the US from 1999 to 2020: A Cross-Sectional Analysis of the CDC WONDER Database.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Mortality trends involving chronic kidney disease and electrolyte and acid-base disorders in the United States, 1999-2023: a CDC WONDER analysis.Annals of medicine and surgery (2012) · 2026Article
- Article
- Bridging methodological gaps in AMI-CKD mortality surveillance: reflections on the CDC WONDER analysis.International urology and nephrology · 2026Article
- Twenty-six-year trends in U.S. mortality among older adults with coexisting chronic kidney disease and atrial fibrillation/flutter.Annals of medicine and surgery (2012) · 2026Review
- Understanding Mortality Data: A Step-by-Step Guide to CDC WONDER, Joinpoint Analysis, and Forecasting Models.Journal of epidemiology and global health · 2026Review
- Enhancing AMI mortality trend analysis in CKD patients: addressing code specificity, comorbidity patterns, and pandemic effects.International urology and nephrology · 2026Article
- Critique on "Mortality trends from acute MI with underlying CKD in the US from 1999 to 2020: a cross-sectional analysis of the CDC WONDER database".International urology and nephrology · 2026Article
- Critical appraisal of "Mortality Trends from Acute MI with Underlying CKD in the US from 1999 to 2020: A Cross-Sectional Analysis of the CDC WONDER Database".International urology and nephrology · 2026Article
- "Exploring benefits of L-carnitine in hemodialysis: promising findings await clinical application".International urology and nephrology · 2025Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeChronic kidney disease increases the risk of acute myocardial infarction and worsens outcomes. Despite advances in care, mortality rate disparities regarding gender, race and socioeconomic status persist. This study examines trends in acute myocardial infarction-related mortality among chronic kidney disease patients in the United States from 1999 to 2020.
methodsWe analyzed mortality data from the CDC WONDER database, identifying deaths with acute myocardial infarction (International Classification of Diseases, 10th Revision [ICD-10] codes I21-I22) as the underlying cause and chronic kidney disease (ICD-10 N18) as a contributing cause. Age-adjusted mortality rates per 100,000, standardized to the 2000 US population, were calculated and stratified by sex, race/ethnicity, urbanization, and state. Trends were assessed using Joinpoint regression to estimate annual percentage change with 95% confidence intervals.
resultsA total of 72,780 acute myocardial infarction-related deaths in chronic kidney disease patients aged 25-85 years occurred from 1999 to 2020. The age adjusted mortality rate declined from 2.46 in 1999 to 0.99 in 2020 (annual percent change: -4.09; 95% CI -5.54 to -2.60). Men had higher mortality than women (age adjusted mortality rate: 2.11 vs. 1.13). Non-Hispanic Black individuals had the highest age adjusted mortality rate (2.90). Nonmetropolitan areas showed higher rates than metropolitan areas (1.63 vs. 1.51). A significant increase in mortality was observed among Hispanic patients from 2015 to 2020 (annual percent change: 8.15; 95% CI 1.13-15.65).
conclusionsAcute myocardial infarction-related mortality in chronic kidney disease patients has declined overall, but persistent disparities by sex, race/ethnicity, and geography highlight the need for continued efforts and targeted interventions in this high-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.